ArticleClinical kidney journal2022

Kynurenine pathway metabolites predict subclinical atherosclerotic disease and new cardiovascular events in chronic kidney disease.

Trista Benitez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.